Astrocytic atrophy as a pathological feature of Parkinson’s disease with LRRK2 mutation

por Paula Ramos-Gonzalez, Susana Mato, Juan Carlos Chara, Alexei Verkhratsky, Carlos Matute, Fabio Cavaliere
Publicado 2021

Differential neuroprotective effects of 5'-deoxy-5'-methylthioadenosine.

por Beatriz Moreno, Iciar Lopez, Begoña Fernández-Díez, Miroslav Gottlieb, Carlos Matute, María Victoria Sánchez-Gómez, María Domercq, Albert Giralt, Jordi Alberch, Kevin W Collon, Helen Zhang, Jack M Parent, Meritxell Teixido, Ernest Giralt, Valentín Ceña, Inmaculada Posadas, Eva Martínez-Pinilla, Pablo Villoslada, Rafael Franco
Publicado 2014

CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson’s disease

por Nora Bengoa-Vergniory, Emilie Faggiani, Paula Ramos-Gonzalez, Ecem Kirkiz, Natalie Connor-Robson, Liam V. Brown, Ibrar Siddique, Zizheng Li, Siv Vingill, Milena Cioroch, Fabio Cavaliere, Sarah Threlfell, Bradley Roberts, Thomas Schrader, Frank-Gerrit Klärner, Stephanie Cragg, Benjamin Dehay, Gal Bitan, Carlos Matute, Erwan Bezard, Richard Wade-Martins
Publicado 2020